Molecular epidemiology and clinical characteristics of Clostridium difficile infection in Thailand

作者
Korakrit Imwattana,Papanin Putsathit,Teera Leepattarakit,Patarachai Kiratisin,Thomas Riley
出处
期刊:International Journal of Infectious Diseases [Elsevier BV]
卷期号:101: 144-144 被引量:1
标识
DOI:10.1016/j.ijid.2020.09.391
摘要

Background: Clostridium difficile infection (CDI) is a public health threat with high mortality and recurrence. Despite its importance, little is known about CDI in Thailand. There has been only one clinical study in the country and microbiological data are limited. Several epidemiologic studies have shown that there is a high prevalence of toxin A-negative, toxin B-positive (A-B+) and non-toxigenic C. difficile in the country, however, disease characteristics have not been determined. Methods and materials: A total of 248 adult cases were included in the CDI group and 221 patients were selected as controls. The definitions of CDI, severe CDI and recurrent CDI were according to the 2017 IDSA/SHEA guidelines. All fecal specimens were cultured for both toxigenic and non-toxigenic C. difficile and all isolates were characterized by ribotyping and toxin gene detection. Patient characteristics and laboratory data were compared between the two groups. Within the CDI group, clinical characteristics were compared between patients infected with A-B+ and A+B+ C. difficile and between patients with and without co-colonizing non-toxigenic C. difficile. Results: There were 271 toxigenic C. difficile isolated; 221 (82%) were A+B+, 47 (17%) were A-B+ and 3 (1%) were binary toxin-positive, one of which was the epidemic ribotype (RT) 078. All A-B+ strains were RT 017 which was the most common RT. Other common RTs include 014 (17%), 020 (7%) and 043 (6%). Overall, 12% (58/469) of the patients were colonized with non-toxigenic C. difficile, with no significant difference between groups. Of the CDI cases, 35% (87/248) had severe disease and 9% (22/248) experienced recurrence. The prevalence of severe cases and recurrence did not differ between patients infected with A-B+ and A+B+ C. difficile, as well as between patients with and without co-colonizing non-toxigenic C. difficile. In the control group, the most common causes of nosocomial diarrhea were drugs, with laxatives (senna, lactulose and milk of magnesia) being the most common agents. Conclusion: The epidemiology of CDI in Thailand was similar to previous reports. Toxin A-B+ strains of C. difficile caused disease with similar characteristics to A+B+ C. difficile, and protective effects of non-toxigenic C. difficile were not observed.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Aoren完成签到,获得积分10
1秒前
1秒前
慕青应助贾cw采纳,获得10
1秒前
小巧的绮完成签到,获得积分10
2秒前
orixero应助ning采纳,获得10
3秒前
Binbin完成签到,获得积分10
3秒前
haihuhu完成签到 ,获得积分10
3秒前
干饭啦完成签到,获得积分10
4秒前
英俊鼠标完成签到 ,获得积分10
4秒前
ln完成签到,获得积分10
4秒前
超级李包包完成签到,获得积分10
5秒前
Baylin发布了新的文献求助10
5秒前
6秒前
汉堡包应助彼方250521采纳,获得10
6秒前
咸鱼打滚发布了新的文献求助10
6秒前
NiaoJiang完成签到,获得积分10
6秒前
7秒前
molihuakai应助cathy采纳,获得10
7秒前
lin完成签到,获得积分10
7秒前
xiaotailan完成签到,获得积分10
7秒前
茶蛋完成签到 ,获得积分10
8秒前
8秒前
大模型应助醉爱星星采纳,获得10
8秒前
9秒前
10秒前
10秒前
11秒前
榴莲姑娘发布了新的文献求助10
12秒前
onlyone发布了新的文献求助10
13秒前
香兰笑完成签到,获得积分20
13秒前
13秒前
LWW完成签到 ,获得积分10
14秒前
烟花应助Baylin采纳,获得10
14秒前
15秒前
完美世界应助listener采纳,获得10
16秒前
16秒前
LQ发布了新的文献求助10
16秒前
okok发布了新的文献求助10
17秒前
现在就出发完成签到,获得积分10
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 500
What is the Future of Psychotherapy in Digital Age? Technology, AI Bots, and Psychotherapy after Covid 444
Management and the Arts 310
Teaching Social and Emotional Learning in Physical Education 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7635894
求助须知:如何正确求助?哪些是违规求助? 9209819
关于积分的说明 19753688
捐赠科研通 7203675
什么是DOI,文献DOI怎么找? 3275289
关于科研通互助平台的介绍 2437151
邀请新用户注册赠送积分活动 2272405